Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Translational Neurodegeneration
Published in: Translational Neurodegeneration 1/2017

Open Access 01-12-2017 | Research

Quercetin prevents spinal motor neuron degeneration induced by chronic excitotoxic stimulus by a sirtuin 1-dependent mechanism

Authors: Rafael Lazo-Gomez, Ricardo Tapia

Published in: Translational Neurodegeneration | Issue 1/2017

Login to get access

Abstract

Background

Excitotoxicity is a mechanism of foremost importance in the selective motor neuron degeneration characteristic of motor neuron disorders. Effective therapeutic strategies are an unmet need for these disorders. Polyphenols, such as quercetin and resveratrol, are plant-derived compounds that activate sirtuins (SIRTs) and have shown promising results in some models of neuronal death, although their effects have been scarcely tested in models of motor neuron degeneration.

Methods

In this work we investigated the effects of quercetin and resveratrol in an in vivo model of excitotoxic motor neuron death induced by the chronic infusion of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) into the rat spinal cord tissue. Quercetin and resveratrol were co-infused with AMPA and motor behavior and muscle strength were assessed daily for up to ten days. Then, animals were fixed and lumbar spinal cord tissue was analyzed by histological and immunocytological procedures.

Results

We found that the chronic infusion of AMPA [1 mM] caused a progressive motor neuron degeneration, accompanied by astrogliosis and microgliosis, and motor deficits and paralysis of the rear limbs. Quercetin infusion ameliorated AMPA-induced paralysis, rescued motor neurons, and prevented both astrogliosis and microgliosis, and these protective effects were prevented by EX527, a very selective SIRT1 inhibitor. In contrast, neither resveratrol nor EX527 alone improved motor behavior deficits or reduced motor neuron degeneration, albeit both reduced gliosis.

Conclusions

These results suggest that quercetin exerts its beneficial effects through a SIRT1-mediated mechanism, and thus SIRT1 plays an important role in excitotoxic neurodegeneration and therefore its pharmacological modulation might provide opportunities for therapy in motor neuron disorders.
Appendix
Available only for authorised users
Literature
1.
Tiryaki E, Horak HA. ALS and other motor neuron diseases. Contin (Minneap Minn). 2014;20:1185–207.
2.
Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma PL. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol. 2013;698:6–18.CrossRefPubMed
3.
King AE, Woodhouse A, Kirkcaldie MTK, Vickers JC. Excitotoxicity in ALS: overstimulation, or overreaction? Exp Neurol. 2016;275:162–71.
4.
Staats KA, Van den Bosch L. Excitotoxicity and amyotrophic lateral sclerosis. Handb. Neurotox. New York: Springer Science+Business Media; 2014. p. 1209–22.
5.
Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, et al. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci. 2002;193:73–8.CrossRefPubMed
6.
Milanese M, Zappettini S, Onofri F, Musazzi L, Tardito D, Bonifacino T, et al. Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. J Neurochem. 2011;116:1028–42.CrossRefPubMed
7.
Bonifacino T, Musazzi L, Milanese M, Seguini M, Marte A, Gallia E, et al. Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease. Neurobiol Dis. 2016;95:122–33.CrossRefPubMed
8.
Tovar-y-Romo LB, Santa-Cruz LD, Tapia R. Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis. Mol Neurodegener. 2009;4:31.CrossRefPubMedPubMedCentral
9.
Corona JC, Tapia R. AMPA receptor activation, but not the accumulation of endogenous extracellular glutamate, induces paralysis and motor neuron death in rat spinal cord in vivo. J Neurochem. 2004;89:988–97.CrossRefPubMed
10.
Corona JC, Tovar-y-Romo LB, Tapia R. Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis. Expert Opin Ther Targets. 2007;11:1415–28.CrossRefPubMed
11.
Ramirez-Jarquin UN, Tapia R. Neuropathological characterization of spinal motor neuron degeneration processes induced by acute and chronic excitotoxic stimulus in vivo. Neuroscience. 2016;331:78–90.CrossRefPubMed
12.
Tovar-y-Romo LB, Zepeda A, Tapia R. Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration. J Neuropathol Exp Neurol. 2007;66:913–22.CrossRefPubMed
13.
Tovar-y-Romo LB, Tapia R. Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo. ASN Neuro. 2012;4:121–9.
14.
Netzahualcoyotzi C, Tapia R. Degeneration of spinal motor neurons by chronic AMPA-induced excitotoxicity in vivo and protection by energy substrates. Acta Neuropathol Commun. 2015;3:27.CrossRefPubMedPubMedCentral
15.
Santa-Cruz LD, Guerrero-Castillo S, Uribe-Carvajal S, Tapia R. Mitochondrial dysfunction during the early stages of Excitotoxic spinal motor neuron degeneration in vivo. ACS Chem Neurosci. 2016;7:886–96.CrossRefPubMed
16.
Ebrahimi A, Schluesener H. Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res Rev. 2012;11:329–45.CrossRefPubMed
17.
Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal. 2013;18:1818–92.CrossRefPubMedPubMedCentral
18.
Min SW, Sohn PD, Cho SH, Swanson RA, Gan L. Sirtuins in neurodegenerative diseases: an update on potential mechanisms. Front Aging Neurosci. 2013;5:53.CrossRefPubMedPubMedCentral
19.
Zhang LN, Hao L, Wang HY, HN S, Sun YJ, Yang XY, et al. Neuroprotective effect of resveratrol against glutamate-induced excitotoxicity. Adv Clin Exp Med. 2015;24:161–5.CrossRefPubMed
20.
Yang EJ, Kim GS, Kim JA, Song KS. Protective effects of onion-derived quercetin on glutamate-mediated hippocampal neuronal cell death. Pharmacogn Mag. 2013;9:302–8.CrossRefPubMedPubMedCentral
21.
Nakayama M, Aihara M, Chen YN, Araie M, Tomita-Yokotani K, Iwashina T. Neuroprotective effects of flavonoids on hypoxia-, glutamate-, and oxidative stress-induced retinal ganglion cell death. Mol Vis. 2011;17:1784–93.PubMedPubMedCentral
22.
Pandey AK, Hazari PP, Patnaik R, Mishra AK. The role of ASIC1a in neuroprotection elicited by quercetin in focal cerebral ischemia. Brain Res. 2011;1383:289–99.CrossRefPubMed
23.
Liu P, Zou D, Yi L, Chen M, Gao Y, Zhou R, et al. Quercetin ameliorates hypobaric hypoxia-induced memory impairment through mitochondrial and neuron function adaptation via the PGC-1alpha pathway. Restor Neurol Neurosci. 2015;33:143–57.PubMed
24.
Lazo-Gomez R, Tapia R. Motor alterations induced by chronic 4-Aminopyridine infusion in the spinal cord in vivo: role of glutamate and GABA receptors. Front Neurosci. 2016;10:200.CrossRefPubMedPubMedCentral
25.
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–82.CrossRefPubMed
26.
27.
Gertz M, Fischer F, Nguyen GT, Lakshminarasimhan M, Schutkowski M, Weyand M, et al. Ex-527 inhibits Sirtuins by exploiting their unique NAD+−dependent deacetylation mechanism. Proc Natl Acad Sci U S A. 2013;110:E2772–81.CrossRefPubMedPubMedCentral
28.
Moshayedi P, Ng G, Kwok JC, Yeo GS, Bryant CE, Fawcett JW, et al. The relationship between glial cell mechanosensitivity and foreign body reactions in the central nervous system. Biomaterials. 2014;35:3919–25.CrossRefPubMed
29.
Ayissi VB, Ebrahimi A, Schluesenner H. Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms. Mol Nutr Food Res. 2014;58:22–32.CrossRefPubMed
30.
Mancuso R, del Valle J, Modol L, Martinez A, Granado-Serrano AB, Ramirez-Nunez O, et al. Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurotherapeutics. 2014;11:419–32.PubMedPubMedCentral
31.
Zakhary SM, Ayubcha D, Dileo JN, Jose R, Leheste JR, Horowitz JM, et al. Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems. Anat Rec. 2010;293:1024–32.CrossRef
32.
Korner S, Boselt S, Thau N, Rath KJ, Dengler R, Petri S. Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS? Neurodegener Dis. 2013;11:141–52.CrossRefPubMed
33.
Lee JC, Shin JH, Park BW, Kim GS, Kim JC, Kang KS, et al. Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis. Brain Res. 2012;1433:20–8.CrossRefPubMed
34.
Valle C, Salvatori I, Gerbino V, Rossi S, Palamiuc L, Rene F, et al. Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways. Cell Death Dis. 2014;5:e1296.CrossRefPubMedPubMedCentral
35.
Cheng Y, Takeuchi H, Sonobe Y, Jin S, Wang Y, Horiuchi H, et al. Sirtuin 1 attenuates oxidative stress via upregulation of superoxide dismutase 2 and catalase in astrocytes. J Neuroimmunol. 2014;269:38–43.CrossRefPubMed
36.
Sidorova-Darmos E, Wither RG, Shulyakova N, Fisher C, Ratnam M, Aarts M, et al. Differential expression of sirtuin family members in the developing, adult, and aged rat brain. Front Aging Neurosci. 2014;6:333.CrossRefPubMedPubMedCentral
37.
Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, et al. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem. 2005;280:17038–45.CrossRefPubMed
38.
Moldzio R, Radad K, Krewenka C, Kranner B, Duvigneau JC, Rausch WD. Protective effects of resveratrol on glutamate-induced damages in murine brain cultures. J Neural Transm. 2013;120:1271–80.CrossRefPubMed
39.
Wang Q, Yu S, Simonyi A, Rottinghaus G, Sun GY, Sun AY. Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem Res. 2004;29:2105–12.CrossRefPubMed
40.
Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. EMBO J. 2007;26:3169–79.CrossRefPubMedPubMedCentral
41.
Wang J, Zhang Y, Tang L, Zhang N, Fan D. Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis. Neurosci Lett. 2011;503:250–5.CrossRefPubMed
42.
Song L, Chen L, Zhang X, Li J, Le W. Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Biomed Res Int. 2014;2014:483501.PubMedPubMedCentral
43.
Beher D, Wu J, Cumine S, Kim KW, SC L, Atangan L, et al. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des. 2009;74:619–24.CrossRefPubMed
44.
45.
Tang BL. Resveratrol is neuroprotective because it is not a direct activator of Sirt1-a hypothesis. Brain Res Bull. 2010;81:359–61.CrossRefPubMed
46.
Lim MA, Selak MA, Xiang Z, Krainc D, Neve RL, Kraemer BC, et al. Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease. J Neurosci. 2012;32:1123–41.CrossRefPubMedPubMedCentral
47.
Friedman LK, Goldstein B, Rafiuddin A, Roblejo P, Friedman S. Lack of resveratrol neuroprotection in developing rats treated with kainic acid. Neuroscience. 2013;230:39–49.CrossRefPubMed
48.
Silva B, Oliveira PJ, Dias A, Malva JO. Quercetin, kaempferol and biapigenin from Hypericum Perforatum are neuroprotective against excitotoxic insults. Neurotox Res. 2008;13:265–79.CrossRefPubMed
49.
Santa-Cruz LD, Tapia R. Role of energy metabolic deficits and oxidative stress in excitotoxic spinal motor neuron degeneration in vivo. ASN Neuro. 2014;6:83–93.
50.
Uzunalli G, Bora-Tatar G, Dayangac-Erden D, Erdem-Yurter H. Effects of flavonoid quercetin on survival of motor neuron gene expression. Cell Biol Int. 2015;39:350–4.CrossRefPubMed
51.
Said Ahmed M, Hung WY, JS Z, Hockberger P, Siddique T. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1. J Neurol Sci. 2000;176:88–94.CrossRefPubMed
52.
Ternaux JP, Portalier P. Effect of quercetine on survival and morphological properties of cultured embryonic rat spinal motoneurones. Neurosci Lett. 2002;332:33–6.CrossRefPubMed
53.
Leyton L, Hott M, Acuna F, Caroca J, Nunez M, Martin C, et al. Nutraceutical activators of AMPK/Sirt1 axis inhibit viral production and protect neurons from neurodegenerative events triggered during HSV-1 infection. Virus Res. 2015;205:63–72.CrossRefPubMed
54.
Ay M, Luo J, Langley M, Jin H, Anantharam V, Kanthasamy A, et al. Molecular mechanisms underlying protective effects of Quercetin against mitochondrial dysfunction and progressive Dopaminergic Neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson’s disease. J Neurochem. 2017;141:766–82.CrossRefPubMed
55.
Ng F, Wijaya L, Tang BL. SIRT1 in the brain-connections with aging-associated disorders and lifespan. Front Cell Neurosci. 2015;9:64.PubMedPubMedCentral
56.
Watanabe S, Ageta-Ishihara N, Nagatsu S, Takao K, Komine O, Endo F, et al. SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system. Mol Brain. 2014;7:62.CrossRefPubMedPubMedCentral
57.
Michan S, Li Y, Chou MM, Parrella E, Ge H, Long JM, et al. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci. 2010;30:9695–707.CrossRefPubMedPubMedCentral
58.
Schuchmann S, Buchheim K, Meierkord H, Heinemann U. A relative energy failure is associated with low-Mg2+ but not with 4-aminopyridine induced seizure-like events in entorhinal cortex. J Neurophysiol. 1999;81:399–403.PubMed
59.
Heinemann U, Buchheim K, Gabriel S, Kann O, Kovacs R, Schuchmann S. Cell death and metabolic activity during epileptiform discharges and status epilepticus in the hippocampus. Prog Brain Res. 2002;135:197–210.CrossRefPubMed
60.
61.
Wang S, Yang X, Lin Y, Qiu X, Li H, Zhao X, et al. Cellular NAD depletion and decline of SIRT1 activity play critical roles in PARP-1-mediated acute epileptic neuronal death in vitro. Brain Res. 2013;1535:14–23.CrossRefPubMed
62.
Martire S, Mosca L, D’Erme M. PARP-1 involvement in neurodegeneration: a focus on Alzheimer’s and Parkinson’s diseases. Mech Ageing Dev. 2015;146–148:53–64.CrossRefPubMed
63.
Liu D, Gharavi R, Pitta M, Gleichmann M, Mattson MP. Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons. NeuroMolecular Med. 2009;11:28–42.CrossRefPubMedPubMedCentral
64.
Liu D, Pitta M, Mattson MP. Preventing NAD(+) depletion protects neurons against excitotoxicity: bioenergetic effects of mild mitochondrial uncoupling and caloric restriction. Ann N Y Acad Sci. 2008;1147:275–82.CrossRefPubMedPubMedCentral
65.
66.
Zhou M, Ottenberg G, Sferrazza GF, Hubbs C, Fallahi M, Rumbaugh G, et al. Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment. Brain. 2015;138:992–1008.CrossRefPubMedPubMedCentral
67.
68.
Metadata
Title
Quercetin prevents spinal motor neuron degeneration induced by chronic excitotoxic stimulus by a sirtuin 1-dependent mechanism
Authors
Rafael Lazo-Gomez
Ricardo Tapia
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Translational Neurodegeneration / Issue 1/2017
Electronic ISSN: 2047-9158
DOI
https://doi.org/10.1186/s40035-017-0102-8

Other articles of this Issue 1/2017

Translational Neurodegeneration 1/2017 Go to the issue

Review

The role of cognitive activity in cognition protection: from Bedside to Bench

Research

Clinical features and genotype-phenotype correlation analysis in patients with ATL1 mutations: A literature reanalysis

Review

Environmental insults: critical triggers for amyotrophic lateral sclerosis

Review

Music therapy is a potential intervention for cognition of Alzheimer’s Disease: a mini-review

Review

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson’s disease

Review

Nicotine from cigarette smoking and diet and Parkinson disease: a review